 |
Bernadette Toner is editorial director for GenomeWeb's premium content. E-mail Bernadette Toner or follow her GenomeWeb Twitter account at @GenomeWeb. |
Survey Finds MiSeq, Ion PGM Tied for Most Likely Sequencing Purchase over Next 12 Months
April 24, 2012
Survey Finds MiSeq, Ion PGM Tied for Most Likely Sequencing Purchase over Next 12 Months
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Researchers Rank MiSeq over PGM for Usability; Expect Their Sequencing Output to Grow by Half in 2013
January 22, 2013 / In Sequence - Survey Finds Researchers Most Likely to Purchase Ion Torrent PGM, MiSeq, HiSeq over Next Year
October 25, 2011 / In Sequence - In Sequence Survey: Illumina Holds Two-Thirds of Sequencing Market, Splits Desktop Share with Ion PGM
October 2, 2012 / In Sequence - In Sequence Annual Survey: Illumina Leads Market but Most Users Believe PacBio Will Provide Next Big Leap
January 25, 2011 / In Sequence - Sequencing Survey Finds Customers Happiest with HiSeq 2500
April 16, 2013 / In Sequence